BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16568458)

  • 21. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease--results from a review of 82 consecutive cases diagnosed between 1992 and 2004.
    Jabbour J; Cumming R; Scolyer RA; Hruby G; Thompson JF; Lee S
    Ann Surg Oncol; 2007 Jun; 14(6):1943-52. PubMed ID: 17356954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined-modality therapy for patients with regional nodal metastases from melanoma.
    Ballo MT; Ross MI; Cormier JN; Myers JN; Lee JE; Gershenwald JE; Hwu P; Zagars GK
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):106-13. PubMed ID: 16182463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma.
    van Akkooi AC; Bouwhuis MG; van Geel AN; Hoedemaker R; Verhoef C; Grunhagen DJ; Schmitz PI; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 Feb; 33(1):102-8. PubMed ID: 17161577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.
    Lee HY; Choi HJ; Park KJ; Shin JS; Kwon HC; Roh MS; Kim C
    Ann Surg Oncol; 2007 May; 14(5):1712-7. PubMed ID: 17253102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease.
    van der Ploeg AP; Haydu LE; Spillane AJ; Scolyer RA; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Thompson JF
    Ann Surg Oncol; 2014 Sep; 21(9):3108-16. PubMed ID: 24802907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors.
    Brand CU; Ellwanger U; Stroebel W; Meier F; Schlagenhauff B; Rassner G; Garbe C
    Cancer; 1997 Jun; 79(12):2345-53. PubMed ID: 9191522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009.
    Pfeil AF; Leiter U; Buettner PG; Eigentler TK; Weide B; Meier F; Garbe C
    Melanoma Res; 2011 Jun; 21(3):228-34. PubMed ID: 21502902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant melanoma of cervical and parotid lymph nodes with an unknown primary site.
    Nasri S; Namazie A; Dulguerov P; Mickel R
    Laryngoscope; 1994 Oct; 104(10):1194-8. PubMed ID: 7934587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
    Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
    Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic variables for patients with stage III malignant melanoma.
    Messaris GE; Konstadoulakis MM; Ricaniadis N; Leandros E; Androulakis G; Karakousis PC
    Eur J Surg; 2000 Mar; 166(3):233-9. PubMed ID: 10755339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
    Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both.
    Jonk A; Kroon BB; Rümke P; van der Esch EP; Hart AA
    Surg Gynecol Obstet; 1988 Jul; 167(1):28-32. PubMed ID: 3289133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lymph node metastasis of melanoma of unknown primary tumor].
    Nguyen T; Avril MF; Charpentier P; Guillaume C; Margulis A; Prade M
    Bull Cancer; 1992; 79(3):291-6. PubMed ID: 1392168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.